Cell Viability Assays Market

The global Cell Viability Assays market was valued at US$ 2579.3 million in 2022 and is projected to reach US$ 3532.2 million by 2029, at a CAGR of 4.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Cell Viability Assays is a type of technique used for determining viable cells in the culture. Cell Viability Assays asses the efficiency of the cells by measuring markers of cellular activity. The cell viability is used to monitor the response and health of the cells in the culture after treatment with various stimuli. Moreover, cell Viability Assays and cytotoxicity assays are used for drug screening and cytotoxicity tests of chemicals.
Cell Viability Assays Market aims to provide a comprehensive presentation of the global market for Cell Viability Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Viability Assays. Cell Viability Assays Market contains market size and forecasts of Cell Viability Assays in global, including the following market information:

• Global Cell Viability Assays Market Revenue, 2018-2023, 2024-2029, ($ millions)
• Global top five companies in 2022 (%)

Numerous factors such as growing prevalence of chronic and infectious diseases, growing availability of funds for cell-based research, rising need of cell-based assays in research and development activities are expected to drive the growth of the market.
We surveyed the Cell Viability Assays companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Viability Assays Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cell Viability Assays Market Segment Percentages, by Type, 2022 (%)

• Human Cells
• Microbial Cells
• Animal Cells

Global Cell Viability Assays Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cell Viability Assays Market Segment Percentages, by Application, 2022 (%)

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Hospital and Diagnostic Laboratories
• Others

Global Cell Viability Assays Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cell Viability Assays Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell Viability Assays revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cell Viability Assays revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• Merck
• Bio-Rad
• GE
• Danaher
• BD
• PerkinElmer
• Promega
• Biotium
• Abcam
• Creative Bioarray
• Biotek Instruments

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Cell Viability Assays, market overview.
• Chapter 2: Global Cell Viability Assays market size in revenue.
• Chapter 3: Detailed analysis of Cell Viability Assays company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Cell Viability Assays in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: The main points and conclusions of the report.

To know more about market statistics, Download a FREE Sample copy